Page 260 - IJB-8-4
P. 260

3D Bioprinting for Lung Tissue Regeneration
               Front Public Health, 8:152.                         NT-proBNP in Patients with Severe COVID-19. Respir Res,
               https://doi.org/10.3389/fpubh.2020.00152            21:83.
           79.  Memtsoudis SG, Ivascu NS, Pryor KO, et al., 2020, Obesity      https://doi.org/10.1186/s12931-020-01352-w
               as a Risk Factor for Poor Outcome in Covid-19-Induced   91.  Yan L, Zhang HT, Goncalves J, et al., 2020, An Interpretable
               Lung Injury: The Potential Role of Undiagnosed Obstructive   Mortality  Prediction  Model  for COVID-19 Patients.  Nat
               Sleep Apnoea. Br J Anaesth, 125:e262–3.             Mach Intell, 2:283–8.
               https://doi.org/10.1016/j.bja.2020.04.078           https://doi.org/10.1038/s42256-020-0180-7
           80.  Simonnet  A, Chetboun M, Poissy J,  et al., 2020, High   92.  Ye  W, Chen G, Li X,  et al., 2020, Dynamic  Changes of
               Prevalence  of Obesity in Severe  Acute Respiratory   D-Dimer  and  Neutrophil-Lymphocyte  Count  Ratio  as
               Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive   Prognostic Biomarkers in COVID-19. Respir Res, 21:169.
               Mechanical Ventilation. Obesity (Silver Spring), 28:1195–9.     https://doi.org/10.1186/s12931-020-01428-7
               https://doi.org/10.1002/oby.22831               93.  Ng WL, Lee JM, Zhou M, et al., 2020, Vat Polymerization-
           81.  Guo W, Li M, Dong Y, et al., 2020, Diabetes is a Risk Factor   Based  Bioprinting-Process, Materials,  Applications  and
               for the Progression and Prognosis of COVID-19. Diabetes   Regulatory Challenges. Biofabrication, 12:022001.
               Metab Res Rev, 36:e3319.                            https://doi.org/10.1088/1758-5090/ab6034
               https://doi.org/10.1002/dmrr.3319               94.  Yu J, Park SA, Kim WD, et al., 2020, Current Advances in
           82.  Rashedi J, Poor BM,  Asgharzadeh  V,  et al., 2020, Risk   3D Bioprinting Technology and Its Applications for Tissue
               Factors for COVID-19. Infez Med, 28:469–74.         Engineering. Polymers (Basel), 12:2958.
           83.  Rajpal A, Rahimi L, Ismail-Beigi F, 2020, Factors Leading to      https://doi.org/10.3390/polym12122958
               High Morbidity and Mortality of COVID-19 in Patients with   95.  Donderwinkel I, van Hest JC, Cameron NR, 2017, Bio-Inks
               Type 2 Diabetes. J Diabetes, 12:895–908.            for 3D Bioprinting: Recent Advances and Future Prospects.
               https://doi.org/10.1111/1753-0407.13085             Polym Chem, 8:4451–71.
           84.  Hayden MR, 2020, Endothelial Activation and Dysfunction   96.  Tan B, Gan S,  Wang X,  et al., 2021, Applications  of 3D
               in Metabolic  Syndrome, Type  2 Diabetes  and Coronavirus   Bioprinting in Tissue Engineering: Advantages, Deficiencies,
               Disease 2019. J Int Med Res, 48:300060520939746.    Improvements,  and Future Perspectives.  J  Mater Chem B,
               https://doi.org/10.1177/0300060520939746            9:5385–413.
           85.  Rubin SJ, Falkson SR, Degner NR,  et al., 2021, Clinical   97.  Bishop ES, Mostafa  S, Pakvasa  M,  et  al., 2017, 3-D
               Characteristics  Associated  with COVID-19 Severity  in   Bioprinting  Technologies  in  Tissue Engineering  and
               California. J Clin Transl Sci, 5:e3.                Regenerative  Medicine:  Current and Future Trends.  Genes
               https://doi.org/10.1017/cts.2020.40                 Dis, 4:185–95.
           86.  Gao YD, Ding M, Dong X,  et  al., 2021, Risk Factors for   98.  Cui H, Nowicki M, Fisher JP, et al., 2017, 3D Bioprinting for
               Severe and Critically Ill COVID-19 Patients:  A  Review.   Organ Regeneration. Adv Healthc Mater, 6:1601118.
               Allergy, 76:428–55.                                 https://doi.org/10.1002/adhm.201601118
               https://doi.org/10.1111/all.14657               99.  Liu N, Ye X, Yao B, et al., 2021, Advances in 3D Bioprinting
           87.  Liu Y, Du X, Chen J, et al., 2020, Neutrophil-to-Lymphocyte   Technology for Cardiac Tissue Engineering and Regeneration.
               Ratio  as an  Independent  Risk Factor  for Mortality  in   Bioact Mater, 6:1388–401.
               Hospitalized Patients with COVID-19. J Infect, 81:e6–12.     https://doi.org/10.1016/j.bioactmat.2020.10.021
               https://doi.org/10.1016/j.jinf.2020.04.002      100.  Cui H, Miao S, Esworthy T, et al., 2018, 3D Bioprinting for
           88.  Qu R, Ling  Y, Zhang  YH,  et al., 2020, Platelet-to-  Cardiovascular Regeneration and Pharmacology. Adv Drug
               Lymphocyte Ratio is Associated with Prognosis in Patients   Deliv Rev, 132:252–69.
               with Coronavirus Disease-19. J Med Virol, 92:1533–41.     https://doi.org/10.1016/j.addr.2018.07.014
               https://doi.org/10.1016/j.jinf.2020.04.002      101.  Ng WL,  Ayi TC,  Liu  YC,  et al., 2021, Fabrication  and
           89.  Liu Y,  Sun  W,  Guo Y,  et al., 2020,  Association between   Characterization  of 3D Bioprinted  Triple-Layered  Human
               Platelet  Parameters  and  Mortality  in  Coronavirus  Disease   Alveolar Lung Models. Int J Bioprint, 7:332.
               2019: Retrospective Cohort Study. Platelets, 31:490–6.     https://doi.org/10.18063/ijb.v7i2.332
               https://doi.org/10.1080/09537104.2020.1754383   102.  Grigoryan  B,  Paulsen  SJ, Corbett  DC,  et  al.,  2019,
           90.  Gao L, Jiang D, Wen XS, et al., 2020, Prognostic Value of   Multivascular  Networks  and  Functional  Intravascular

           252                         International Journal of Bioprinting (2022)–Volume 8, Issue 4
   255   256   257   258   259   260   261   262   263   264   265